Literature DB >> 34183055

Cardiac effects and clinical applications of MG53.

Weina Zhong1, Dathe Z Benissan-Messan1, Jianjie Ma1, Chuanxi Cai2, Peter H U Lee3,4,5.   

Abstract

Heart disease remains the leading cause of mortality globally, so further investigation is required to identify its underlying mechanisms and potential targets for treatment and prevention. Mitsugumin 53 (MG53), also known as TRIM72, is a TRIM family protein that was found to be involved in cell membrane repair and primarily found in striated muscle. Its role in skeletal muscle regeneration and myogenesis has been well documented. However, accumulating evidence suggests that MG53 has a potentially protective role in heart tissue, including in ischemia/reperfusion injury of the heart, cardiomyocyte membrane injury repair, and atrial fibrosis. This review summarizes the regulatory role of MG53 in cardiac tissues, current debates regarding MG53 in diabetes and diabetic cardiomyopathy, as well as highlights potential clinical applications of MG53 in treating cardiac pathologies.

Entities:  

Keywords:  Cardioprotection; Diabetes; Heart disease; MG53; Membrane repair

Year:  2021        PMID: 34183055     DOI: 10.1186/s13578-021-00629-x

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  68 in total

Review 1.  Preconditioning versus postconditioning: mechanisms and therapeutic potentials.

Authors:  Paul R Crisostomo; George M Wairiuko; Meijing Wang; Ben M Tsai; Eric D Morrell; Daniel R Meldrum
Journal:  J Am Coll Surg       Date:  2006-02-21       Impact factor: 6.113

2.  No risk, no ... cardioprotection? A critical perspective.

Authors:  Gerd Heusch
Journal:  Cardiovasc Res       Date:  2009-08-27       Impact factor: 10.787

3.  SPRY domains in ryanodine receptors (Ca(2+)-release channels).

Authors:  C Ponting; J Schultz; P Bork
Journal:  Trends Biochem Sci       Date:  1997-06       Impact factor: 13.807

4.  MG53 constitutes a primary determinant of cardiac ischemic preconditioning.

Authors:  Chun-Mei Cao; Yan Zhang; Noah Weisleder; Christopher Ferrante; Xianhua Wang; Fengxiang Lv; Yi Zhang; Ruisheng Song; Moonsun Hwang; Li Jin; Jiaojiao Guo; Wei Peng; Geng Li; Miyuki Nishi; Hiroshi Takeshima; Jianjie Ma; Rui-Ping Xiao
Journal:  Circulation       Date:  2010-06-01       Impact factor: 29.690

5.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

6.  Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity.

Authors:  C Steenbergen; M L Hill; R B Jennings
Journal:  Circ Res       Date:  1985-12       Impact factor: 17.367

7.  MG53 nucleates assembly of cell membrane repair machinery.

Authors:  Chuanxi Cai; Haruko Masumiya; Noah Weisleder; Noriyuki Matsuda; Miyuki Nishi; Moonsun Hwang; Jae-Kyun Ko; Peihui Lin; Angela Thornton; Xiaoli Zhao; Zui Pan; Shinji Komazaki; Marco Brotto; Hiroshi Takeshima; Jianjie Ma
Journal:  Nat Cell Biol       Date:  2008-11-30       Impact factor: 28.824

8.  Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.

Authors:  Chuanxi Cai; Noah Weisleder; Jae-Kyun Ko; Shinji Komazaki; Yoshihide Sunada; Miyuki Nishi; Hiroshi Takeshima; Jianjie Ma
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

9.  The tripartite motif family identifies cell compartments.

Authors:  A Reymond; G Meroni; A Fantozzi; G Merla; S Cairo; L Luzi; D Riganelli; E Zanaria; S Messali; S Cainarca; A Guffanti; S Minucci; P G Pelicci; A Ballabio
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

Review 10.  TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases.

Authors:  Germana Meroni; Graciana Diez-Roux
Journal:  Bioessays       Date:  2005-11       Impact factor: 4.345

View more
  1 in total

1.  TRIM72 exerts antitumor effects in breast cancer and modulates lactate production and MCT4 promoter activity by interacting with PPP3CA.

Authors:  Zheng Wang; Haixia Li; Hongxia Wang; Xin Li; Qiong Zhang; Haifang Wang; Kui Li; Yurong Qiu
Journal:  Anticancer Drugs       Date:  2022-06-01       Impact factor: 2.248

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.